Search results
Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up
Zacks via Yahoo Finance· 10 hours agoAll growth rates mentioned below are on a year-on-year...Segment Performance Sanofi’s Biopharma...
With whooping cough cases on the rise, do you need a booster vaccine?
Fox News via Yahoo News· 3 days agoAs whooping cough (pertussis) cases surge globally, experts offer their insights on symptoms,...
China's drugmakers can't sell mRNA shots but haven't quit yet
Reuters via AOL· 7 days agoChina's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are...
Study confirms effectiveness of bivalent COVID-19 vaccine
Medical Xpress· 5 hours agoThe study confirmed the vaccine's effectiveness and its importance to control of the disease, while...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 9 hours agoWelireg recorded sales of $85 million, up 102% year over year. In vaccines, sales of HPV vaccines —...
New ‘One-And-Done’ Vaccine Method Could Protect Infants—From Covid, Flu—With Just A Single Shot,...
Forbes· 1 week agoThis new vaccine strategy—tested on mice—also uses a modified version of a virus, but instead of...
Election spoiler? How President Biden's allies hope to stop Robert F. Kennedy Jr.
USA TODAY via Yahoo News· 2 weeks agoAt the same time Kennedy touts his environmentalism credentials in appeal to left-leaning votes, for...
Sanofi (SNY) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 8 hours agoLaunches also boosted the performance in vaccines with Beyfortus making further progress, including in countries in the southern hemisphere...is becoming...
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Market Watch· 15 hours agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts’ expectations amid...
Merck's Cancer Drug and Vaccine Sales Drive Better-Than-Expected Results
Investopedia· 18 hours agoMerck (MRK) shares advanced in intraday trading Thursday after the pharmaceutical firm reported...
